Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis
The Knee, 2026;63:104639
The Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice
Dermatology and therapy, 2026
Reduced Risk in Melanoma and Nonmelanoma Skin Cancers in Obese Patients on Semaglutide and Tirzepatide
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2026
GLP-1 receptor agonism in Alzheimer’s disease after EVOKE: From single hypothesis to stratified program
Journal of Alzheimer's disease : JAD, 2026;:13872877261485580
Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Intestinal research, 2026
Carbon Emission Impact of Semaglutide in People with Obesity in the UK Using a Disease Modelling Approach
PharmacoEconomics, 2026
Wegovy: GPs are told not to prescribe GLP semaglutide for heart health without funding guarantee
BMJ (Clinical research ed.), 2026;394:e100816
Increased Energy Expenditure through Intermittent Cold Exposure Does Not Enhance Tirzepatide Induced Weight-loss in Obese Mice
American journal of physiology. Regulatory, integrative and comparative physiology, 2026
Tirzepatide and oral progestogens: A hypothesis-generating review of a biologically plausible pharmacokinetic interaction in gynaecologic disease control and menopausal hormone therapy
Maturitas, 2026;214:109116
CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL
Canadian journal of physiology and pharmacology, 2026
Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review
World journal of clinical pediatrics, 2026;15(3):118730
Semaglutide and Tirzepatide for the treatment of MASH: What Works, What’s Coming, and What’s Missing
Digestion, 2026;:1
Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials
Journal of the American Heart Association, 2026;:e044249
Water-Soluble, Enzyme-Degradable, and Hydrolyzable STAR Particles for Enhanced Drug Delivery to Skin
Advanced healthcare materials, 2026;:e71569
Anesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty
Aesthetic plastic surgery, 2026
Cell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis
Pharmacology & therapeutics, 2026;:109123
Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials
Endocrinology, diabetes & metabolism;9(5):e70313
Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics
Diabetes, obesity & metabolism, 2026
A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability
Diabetes, obesity & metabolism, 2026